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documented in the literature in the con-
text of simple transposition of the great
vessels but was not discussed further in
this study. The arterial switch compo-
nent of the double-switch procedure
carries all the known risk hazards as
in any arterial switch and long-term
complications, including fatal arrhyth-
mias, neoaortic regurgitation, and left
ventricular dysfunction.3 These risks
can behigher among thosewith a single
orifice coronary artery.
Training is a relative term and is
tailored to the individual patient.
Excessive training leading to LV pres-
sures more than 75% systemic is
a well-known association with late ven-
tricular dysfunction.Although the study
states that LV pressures were 65% to
80%, it would be more informative to
the reader if the authors explained the
target pressures for the 24 patients after
PAbanding in the nontrained subgroup.
Furthermore, approximately 46% (n¼
5) of the trained subgroup had more
than 1 PA band to properly prepare the
morphologic LV (mLV) for the double
switch. It would be important to know
whether such patients’ ventricles fared
better than the application of singleton
pressure load PA banding, especially
when not all LV training is detrimental
in older patients.
It is interesting to note that the mLV/
mRV pressure ratio was similar in the
trained and nontrained groups at the
time of their anatomic repair. However,
those older patients with LV dysfunc-
tion achieved mLV/mRV pressure in
less time (436 vs 730 days) than those
without dysfunction. This may imply
that the LV was generating the same
pressure at the time of the double switch
as in those with ventricular defect phys-
iology (increased end-diastolic volume,
reduced afterload) but fared better than
in the trained group. This may illustrate
that the PA band is a confounder, whe-
reas the morphology (congenitally
corrected transposition of the great ar-
teries with small restrictive ventricular
septal defect or no ventricular septal
defect) is an independent predictor,
especially when the authors state in
Table 1 that 20% of the nontrained
group had good mLV versus 60% in
the trained group (P ¼ .04, statistically
significant). Furthermore, in support of
this is the well-known association of
worsening survival in the older infant
with transposition of the great arteries
and an intact ventricular septum after
the arterial switch compared with trans-
position of the great arteries and a ven-
tricular septal defect.4 The additional
benefit of ventricle volume load via
a systemic circulation to PA shunt to
the pressure load PA band afterload
has been described and could be of ben-
efit in corrected transposition.5 Finally,
the ventricular activation time period
(QRS) has been a strong marker of ven-
tricular function.6 The authors did not
state its respective duration for the 2
groups before and after the double
switch. I would appreciate the authors’
response based on their vast experience
when managing this unique group of
patients.
Jeffrey Shuhaiber, MD
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To the Editor:
We read with great interest the letter
to the editor by Sersar and Jamjoom1
in the Journal of November 2008, de-
scribing the use of the Contegra (Med-
tronic Inc, Minneapolis, MN) bovine
jugular vein as a possible alternative
extracardiac conduit in total cavopul-
monary connection (TCPC).
We want to emphasize our bad ex-
perience with this particular conduit
in patients undergoing the Fontan pro-
cedure, which was published in the
Journal 7 years ago.2
The only 3 patients in whom the
Contegra conduit was used for TCPC
all experienced serious complications
of conduit thrombosis; 2 of them died
and 1 survived, but with major neuro-
logic injury. The Contegra implanta-
tion was carried out at different
institutions by different surgeons.
Evidence has meanwhile accumu-
lated that thrombogenicity is indeed
an inherent characteristic of the Conte-
gra bovine jugular venous conduit.
Thrombus formation has been shown
to occur even in high-flow right ventric-
ular to pulmonary artery conditions.3,4
A fatal case of conduit thrombosis
also occurred at the authors’ institution.
Thiswas publishedbyBaslaim5 in2008
(1 of 18 patients undergoing operation
between 2002 and 2005). An ‘‘opera-
tive technical cause’’ is suggested by
the author as a possible cause.
We are looking forward to the struc-
tured clinical and echocardiographic
follow-up in their patients. For the pres-
ent,we continue todiscourage the use of
the Contegra bovine jugular vein as an
extracardiac conduit in TCPC.
Paul Schoof, MD, PhD
Tjalling Waterbolk, MD
Divisions of Cardiothoracic Surgery
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search regarding the possible mecha-
nisms behind this unusual occurrence,
we analyzed our histopathologic find-
ings. We found that there was likely
pannus formation and collagen infil-
tration through the porous structure
that could account for progressive dis-
ruption before calcification ensued,
which could be postulated as a form
of repair/scarring.
In addition to the degenerative
causes that could be responsible for
the late rupture, we believe that the
use of forceps and other metal instru-
ments in the manipulation of the
ePTFE could interrupt its electronega-
tive charge and weaken the material.
early after operation (in 29 patients)
and an assessment of clinical end
points, such as intensive therapy unit
and hospital stay andmortality. In con-
trast with experience in chronic heart
failure, they showed no advantage to
biventricular pacing in any area, al-
though the trial was underpowered
for the clinical end points.
They suggest this was the first ran-
domized study in surgical patients but
did not cite our 2005 publication.2
We performed a similar randomized
crossover study, with hemodynamic
assessment of different pacing modes
in a similar number of patients (25)
early after surgery. We demonstrated
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In the February issue of the Journal,
Farivar and colleagues1 described
a case of late rupture of expanded
polytetrafluoroethylene (ePTFE) neo-
chordae after mitral valve repair. In the
‘‘Discussion,’’ they state that there
was only 1 previous case reported in
the literature of ruptured neochordae,
presented by Buttany and colleagues,2
suggesting their case as the second re-
ported. This is not correct. In 2007, the
Journal of Heart Valve Disease pub-
lished our report of 2 cases of acute mi-
tral regurgitation caused by ruptured
ePTFE neochordae.3 Our patients pre-
sented with symptoms of acute heart
failure caused by sudden rupture of the
chordae, which was different from the
rare clinical manifestations, hemolysis,
and hematuria experienced by the pa-
tient reportedbyFarivar and colleagues.
We first used ePTFE routinely to
correct ruptured or elongated chordae
tendineae during the late 1980s and
have since implanted it in more than
500 patients without a single known
case of ePTFE failure necessitating re-
operation, until these 2 late events oc-
curred. After a thorough literature
We currently avoid any kind of metal-
lic manipulation.
Gonc¸alo Coutinho, MD
Lina Carvalho, MD, PhD
Manuel J. Antunes, MD, PhD, DSc
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We read with interest the article by
Evonich and colleagues1 in the Octo-
ber issue of the Journal. They per-
formed a randomized study of pacing
modes (‘‘normal care,’’ synchronous
atrial-right ventricular pacing, and
synchronous atrial–biventricular pac-
ing) in 40 patients with impaired left
ventricular function after cardiac sur-
gery. They included both a crossover
study of acute hemodynamic variables
a clear advantage to atrial–left ventric-
ular pacing and regard this modality as
an important addition to the postopera-
tive care of the compromised patient.
Closer analysis of the results in the
article by Evonich and colleagues1
suggests that there is a serious error
or that they too found an advantage
but did not recognize it. In the second
paragraph of the section titled ‘‘Hemo-
dynamic Testing,’’ they state a statisti-
cally significant difference in stroke
volume, cardiac output, and left ven-
tricular stroke work index between
AAI and atrial-right ventricular pacing.
But, in Table 2, the values they refer to
in the text are in the column under
atrial–biventricular pacing pacing. If
Table 2 is to be believed (and there is
inconsistency in nomenclature, does
AAI equate to ‘‘usual care’’?), these
investigators did see an advantage to
biventricular pacing.
We believe biventricular pacing is
of advantage to the postsurgical pa-
tient. Even if we are mistaken in our
interpretation of this article, surgeons
are left with 2 series of patients with
contrasting results, perhaps because
both have small numbers. This calls
for a larger definitive study.
Michael Flynn, FRCS
John H. Dark, FRCS
Janet M. McComb, FRCP, MD
University of Newcastle upon Tyne
United Kingdom
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